Skip to main content

Table 1 General characteristics

From: Illness perceptions of gout patients and the use of allopurinol in primary care: baseline findings from a prospective cohort study

  

Using allopurinol

Factor

Frequency (%)

No (%)

Yes (%)

Age Mean (SD)

65.6 (12.5)

65.1 (13.4)

65.9 (11.6)

Gender (Male %)

990 (83.6)

390 (79.6)

544 (86.4)

Alcohol Consumption

 Never

113 (9.7)

50 (10.4)

56 (9.0)

 Occasionally

155 (13.3)

63 (13.1)

86 (13.8)

 1–3 times per month

109 (9.3)

47 (9.8)

57 (9.0)

 1–2 times per week

254 (21.8)

110 (22.9)

129 (20.6)

 3–4 times per week

263 (22.5)

102 (21.3)

148 (23.7)

 Daily

273 (23.4)

108 (22.5)

149 (23.8)

Body Mass Index

 Normal (<25 kg/m2)

371 (31.3)

168 (34.3)

178 (28.2)

 Overweight/obese (≥25 kg/m2)

813 (68.7)

322 (65.7)

452 (71.8)

Neighbourhood Deprivation Status

 20 % least deprived

410 (34.6)

174 (35.5)

214 (34.0)

 Mid-deprived

405 (34.2)

160 (32.7)

228 (36.2)

 20 % most deprived

369 (31.2)

156 (31.8)

188 (29.8)

Depression (PHQ-9)

131 (11.1)

46 (11.0)

76 (13.4)

Anxiety (GAD-7)

109 (10.0)

42 (9.3)

59 (10.0)

Type II Diabetes Mellitus

205 (17.3)

60 (12.2)

138 (21.9)

Stroke

37 (3.1)

12 (2.5)

24 (3.8)

Hypertension

731 (61.7)

274 (55.9)

414 (65.7)

Transient Ischaemic Attack

62 (5.2)

24 (4.9)

34 (5.4)

Hyperlipidaemia

508 (42.9)

190 (38.8)

291 (46.2)

Kidney Failure

56 (4.7)

18 (3.7)

31 (4.9)

Myocardial Infarction

119 (10.1)

44 (9.0)

67 (10.6)

Kidney Stones

81 (6.8)

23 (4.7)

51 (8.1)

Angina

147 (12.4)

49 (10.0)

88 (14.0)

  1. SD standard deviation, PHQ-9 personalised health questionnaire-9, GAD-7 generalised anxiety disorder 7 questionnaire